These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8099697)

  • 1. Clinical pharmacology of long-acting beta-receptor agonists.
    Tattersfield AE
    Life Sci; 1993; 52(26):2161-9. PubMed ID: 8099697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological similarities and differences between beta2-agonists.
    Lötvall J
    Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting beta 2-agonists.
    Tattersfield AE
    Clin Exp Allergy; 1992 Jun; 22(6):600-5. PubMed ID: 1356604
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of action of inhaled vs. Intravenous beta(2)-adrenoceptor agonists in an anaesthetized guinea-pig model.
    Mohammed SP; Taylor CV; Weyman-Jones CB; Mather ME; Vendy K; Dougall IG; Young A
    Pulm Pharmacol Ther; 2000; 13(6):287-92. PubMed ID: 11061983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmeterol: a novel, long-acting beta 2-agonist.
    Meyer JM; Wenzel CL; Kradjan WA
    Ann Pharmacother; 1993 Dec; 27(12):1478-87. PubMed ID: 7905757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
    Anderson GP
    Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol.
    Nials AT; Ball DI; Butchers PR; Coleman RA; Humbles AA; Johnson M; Vardey CJ
    Eur J Pharmacol; 1994 Jan; 251(2-3):127-35. PubMed ID: 8149969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction.
    Politiek MJ; Boorsma M; Aalbers R
    Eur Respir J; 1999 May; 13(5):988-92. PubMed ID: 10414394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
    Lindén A; Bergendal A; Ullman A; Skoogh BE; Löfdahl CG
    Thorax; 1993 May; 48(5):547-53. PubMed ID: 8100652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.
    Anderson P; Lötvall J; Lindén A
    Lung; 1996; 174(3):159-70. PubMed ID: 8830192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
    Lindén A; Rabe KF; Löfdahl CG
    Lung; 1996; 174(1):1-22. PubMed ID: 8746998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
    Cooper PR; Kurten RC; Zhang J; Nicholls DJ; Dainty IA; Panettieri RA
    Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.
    Bergendal A; Lindén A; Lötvall J; Skoogh BE; Löfdahl CG
    Br J Pharmacol; 1995 Apr; 114(7):1478-82. PubMed ID: 7606351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action.
    Celik G; Kayacan O; Beder S; Durmaz G
    Respiration; 1999; 66(5):434-9. PubMed ID: 10516540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease.
    Cazzola M; Santangelo G; Piccolo A; Salzillo A; Matera MG; D'Amato G; Rossi F
    Pulm Pharmacol; 1994 Apr; 7(2):103-7. PubMed ID: 7915921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of action and duration of effect of formoterol and salmeterol compared to salbutamol in isolated guinea pig trachea with or without epithelium.
    Ullman A; Bergendal A; Lindén A; Waldeck B; Skoogh BE; Löfdahl CG
    Allergy; 1992 Aug; 47(4 Pt 2):384-7. PubMed ID: 1360770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting inhaled beta2-agonists in asthma therapy.
    Moore RH; Khan A; Dickey BF
    Chest; 1998 Apr; 113(4):1095-108. PubMed ID: 9554653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.